Somewhat surprisingly, the list of target promoters failed to include most MLL-AF9 ChIP targets (Bernt et al., 2011) with the leukemia self-renewal associated Hox gene signature, namely Hoxa9, Hoxa10 and Meis1, escaping Kat2a-dependent promoter acetylation control. This evidence concerns the gene MLLT3 and leukemia.